Transcript
Page 1: Study (GEN HAT) is the largest antihypertensive pharmacogenetic study ever conducted which leverages rich clinical data collected as part of the Antihypertensive and Lipid lowering
Page 2: Study (GEN HAT) is the largest antihypertensive pharmacogenetic study ever conducted which leverages rich clinical data collected as part of the Antihypertensive and Lipid lowering
Page 3: Study (GEN HAT) is the largest antihypertensive pharmacogenetic study ever conducted which leverages rich clinical data collected as part of the Antihypertensive and Lipid lowering
Page 4: Study (GEN HAT) is the largest antihypertensive pharmacogenetic study ever conducted which leverages rich clinical data collected as part of the Antihypertensive and Lipid lowering
Page 5: Study (GEN HAT) is the largest antihypertensive pharmacogenetic study ever conducted which leverages rich clinical data collected as part of the Antihypertensive and Lipid lowering
Page 6: Study (GEN HAT) is the largest antihypertensive pharmacogenetic study ever conducted which leverages rich clinical data collected as part of the Antihypertensive and Lipid lowering
Page 7: Study (GEN HAT) is the largest antihypertensive pharmacogenetic study ever conducted which leverages rich clinical data collected as part of the Antihypertensive and Lipid lowering
Page 8: Study (GEN HAT) is the largest antihypertensive pharmacogenetic study ever conducted which leverages rich clinical data collected as part of the Antihypertensive and Lipid lowering
Page 9: Study (GEN HAT) is the largest antihypertensive pharmacogenetic study ever conducted which leverages rich clinical data collected as part of the Antihypertensive and Lipid lowering
Page 10: Study (GEN HAT) is the largest antihypertensive pharmacogenetic study ever conducted which leverages rich clinical data collected as part of the Antihypertensive and Lipid lowering
Page 11: Study (GEN HAT) is the largest antihypertensive pharmacogenetic study ever conducted which leverages rich clinical data collected as part of the Antihypertensive and Lipid lowering
Page 12: Study (GEN HAT) is the largest antihypertensive pharmacogenetic study ever conducted which leverages rich clinical data collected as part of the Antihypertensive and Lipid lowering